News
The Trump administration maintains that HIV meds have survived foreign aid cuts. In Zambia, as in other countries, people are struggling to find pills and risk getting sick without medication.
A University of Utah biochemist found himself on Time Magazine's 100 most influential people of 2025 list alongside names ...
16h
Zacks Investment Research on MSNShould You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report first-quarter 2025 results on April 24, after market close.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results